MDS Nordion Secures Cobalt-60 Supply Agreement with Ontario Power Generation until 2020
August 13 2010 - 6:00AM
PR Newswire (Canada)
OTTAWA, Aug. 13 /CNW/ -- OTTAWA, Aug. 13 /CNW/ - MDS Nordion, a
leading provider of products and services to the global health
science market, today announced it has extended its existing
agreement with Ontario Power Generation Inc. (OPG), the
Canadian-based electricity generation company, until 2020 for the
secure supply of cobalt-60 used in gamma sterilization technologies
around the world. Under the terms of the agreement, OPG will
continue to supply raw materials to MDS Nordion for use in their
medical sterilization and sealed source products. The agreement
provides MDS Nordion with additional long-term supply for its
global customer base. "Executing on this agreement demonstrates to
our current and prospective customers that the Company remains
committed to securing long-term supply of cobalt-60," says Jill
Chitra, Senior Vice-President, Strategic Technologies and
Regulatory Affairs. "It also enables MDS Nordion to continue
building on its strong market position in the sterilization
industry." Approximately 40 per cent of single use medical devices
produced worldwide are sterilized using gamma sterilization
technologies. These include disposable medical devices and supplies
such as surgeon's gloves, syringes, sutures and catheters, as well
as pharmaceuticals. Many organizations use gamma sterilization for
the purpose of disinfestation of fruits and vegetables to meet
international quarantine regulations. In addition, it can be used
to sterilize cosmetic products and to enhance the material
properties of polymers. "We continue to build on our solid
partnership with MDS Nordion," said Bill Robinson, Executive Vice
President, Nuclear Refurbishment, OPG. "This supply agreement
demonstrates OPG's commitment to MDS Nordion as a valued customer
and highlights a significant contribution made by Nuclear Power to
society well being." About MDS Inc. MDS Inc. (TSX: MDS; NYSE: MDZ)
is a global health science company that provides market-leading
products and services used for the prevention, diagnosis and
treatment of disease. We are a leading provider of innovative
technologies for use in medical imaging and radiotherapeutics, and
sterilization technologies benefiting the lives of millions of
people in more than 65 countries around the world. Our products and
services are used daily by pharmaceutical and biotechnology
companies, medical-device manufacturers, hospitals, clinics and
research laboratories. MDS has more than 700 highly skilled people
in five locations. Find out more at www.mdsnordion.com. MEDIA:
Shelley Maclean, (613) 592-3400, ext. 2414,
shelley.maclean@mdsinc.com; INVESTORS: Ana Raman, (613) 595-4580,
investor.relations@mdsinc.com
Copyright
Mds (NYSE:MDZ)
Historical Stock Chart
From May 2024 to Jun 2024
Mds (NYSE:MDZ)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Mds (New York Stock Exchange): 0 recent articles
More Mds News Articles